US Hematology Diagnostics Market

Longer Product Cycles Stall Market Growth

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
26-Jun-2014
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
NDE2-01-00-00-00
SKU
LS00044-NA-MR_16885
Yes
SHARE

US Hematology Diagnostics Market
Published on: 26-Jun-2014 | SKU: LS00044-NA-MR_16885

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician’s office laboratories.

Key Findings

Scope and Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

Market Engineering Measurements (continued)

CEO’s Perspective

Key Companies to Watch

Executive Summary—2 Big Predictions

Market Segmentation

Market Segmentation (continued)

Customer Segmentation and Landscape

Most Commonly Ordered Hematology Tests

Defining Healthcare Trends in the Future

New Market Opportunities

New Market Opportunities (continued)

New Market Opportunities (continued)

Merger, Acquisition, and Partnership Assessment

Merger, Acquisition, and Partnership Assessment (continued)

Market Drivers

Market Restraints

Market Engineering Measurements

Forecast Assumptions and Definitions

Revenue Forecast

Revenue Forecast Discussion

Procurement Process

PEST Analysis

Competitive Structure

Market Share

Market Share Analysis

Market Share Analysis (continued)

Market Share Analysis (continued)

Sysmex—Company Dashboard

Beckman Coulter (Danaher)—Company Dashboard

Abbott Diagnostics—Company Dashboard

Horiba ABX—Company Dashboard

Siemens Healthcare Diagnostics—Company Dashboard

Popularity Trend by Model Type

Popularity Trend by Model Type (continued)

Popularity Trend by Model Type (continued)

Popularity Trend by Model Type (continued)

Popularity Trend by Model Type (continued)

Popular Models—Pricing Analysis

Popular Models—Pricing Analysis (continued)

Revenue Forecast

Revenue Forecast Discussion

Installed Base and Pricing Analysis

Revenue Forecast

Revenue Forecast Discussion

The Last Word—2 Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

Legal Disclaimer

Market Definitions

Market Definitions (continued)

Market Background

Market Background (continued)

Market Background (continued)

Market Background (continued)

Hematology Tests and CPT Codes

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Market Engineering Methodology

Associated Market Research Services

Learn More—Next Steps


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physicians office laboratories.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number NDE2-01-00-00-00
Is Prebook No

US Hematology Diagnostics Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00044-NA-MR_16885